STERIS plc $STE Shares Sold by Corient Private Wealth LLC

Corient Private Wealth LLC trimmed its stake in STERIS plc (NYSE:STE) by 6.7% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 51,029 shares of the medical equipment provider’s stock after selling 3,642 shares during the quarter. Corient Private Wealth LLC owned approximately 0.05% of STERIS worth $12,258,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Spurstone Advisory Services LLC purchased a new position in STERIS in the 2nd quarter worth about $29,000. Geneos Wealth Management Inc. boosted its holdings in shares of STERIS by 416.0% in the first quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 104 shares during the period. Loomis Sayles & Co. L P acquired a new position in shares of STERIS in the second quarter worth about $54,000. Generali Investments Management Co LLC purchased a new position in shares of STERIS in the second quarter worth approximately $56,000. Finally, CYBER HORNET ETFs LLC purchased a new position in shares of STERIS in the second quarter worth approximately $62,000. 94.69% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, VP John Adam Zangerle sold 15,000 shares of the stock in a transaction that occurred on Tuesday, November 11th. The stock was sold at an average price of $265.14, for a total transaction of $3,977,100.00. Following the completion of the sale, the vice president owned 33,669 shares in the company, valued at $8,926,998.66. This represents a 30.82% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, VP Renato Tamaro sold 5,036 shares of the stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $257.55, for a total value of $1,297,021.80. Following the completion of the sale, the vice president directly owned 5,695 shares of the company’s stock, valued at $1,466,747.25. This represents a 46.93% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 25,203 shares of company stock worth $6,624,667 over the last quarter. 1.07% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

STE has been the subject of a number of recent analyst reports. Wall Street Zen raised shares of STERIS from a “buy” rating to a “strong-buy” rating in a research note on Sunday, September 14th. Weiss Ratings restated a “buy (b)” rating on shares of STERIS in a report on Tuesday, October 14th. Seven research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $273.50.

STERIS Price Performance

NYSE STE opened at $251.54 on Friday. The stock has a market capitalization of $24.69 billion, a PE ratio of 36.14 and a beta of 1.01. STERIS plc has a 12-month low of $200.98 and a 12-month high of $268.60. The company has a 50 day moving average price of $252.19 and a two-hundred day moving average price of $244.05. The company has a quick ratio of 1.63, a current ratio of 2.37 and a debt-to-equity ratio of 0.27.

STERIS (NYSE:STE) last posted its earnings results on Wednesday, November 5th. The medical equipment provider reported $2.47 earnings per share for the quarter, beating the consensus estimate of $2.38 by $0.09. STERIS had a return on equity of 14.43% and a net margin of 12.07%.The company had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.43 billion. During the same period last year, the company earned $2.14 earnings per share. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. As a group, equities analysts predict that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, December 18th. Investors of record on Tuesday, November 18th were issued a $0.63 dividend. This represents a $2.52 annualized dividend and a yield of 1.0%. The ex-dividend date was Tuesday, November 18th. STERIS’s dividend payout ratio (DPR) is 36.21%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.